Global Neprilysin Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Neprilysin Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Neprilysin Market Size Growth Rate by Product
  • 1.4.2 TD-0714
  • 1.4.3 STR-324
  • 1.4.4 PL-265
  • 1.4.5 LHW-090
  • 1.4.6 Others
• 1.5 Market by End User
  • 1.5.1 Global Neprilysin Market Size Growth Rate by End User
  • 1.5.2 Acute Heart Failure
  • 1.5.3 Cancer Pain
  • 1.5.4 Hypertension
  • 1.5.5 Alzheimer's Disease
  • 1.5.6 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Neprilysin Market Size
  • 2.1.1 Global Neprilysin Revenue 2014-2025
  • 2.1.2 Global Neprilysin Sales 2014-2025
• 2.2 Neprilysin Growth Rate by Regions
  • 2.2.1 Global Neprilysin Sales by Regions
  • 2.2.2 Global Neprilysin Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Neprilysin Sales by Manufacturers
  • 3.1.1 Neprilysin Sales by Manufacturers
  • 3.1.2 Neprilysin Sales Market Share by Manufacturers
  • 3.1.3 Global Neprilysin Market Concentration Ratio (CR5 and HHI)
• 3.2 Neprilysin Revenue by Manufacturers
  • 3.2.1 Neprilysin Revenue by Manufacturers (2014-2019)
  • 3.2.2 Neprilysin Revenue Share by Manufacturers (2014-2019)
• 3.3 Neprilysin Price by Manufacturers
• 3.4 Neprilysin Manufacturing Base Distribution, Product Types
  • 3.4.1 Neprilysin Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Neprilysin Product Type
  • 3.4.3 Date of International Manufacturers Enter into Neprilysin Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Neprilysin Sales by Product
• 4.2 Global Neprilysin Revenue by Product
• 4.3 Neprilysin Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Neprilysin Breakdown Data by End User

6 North America

• 6.1 North America Neprilysin by Countries
  • 6.1.1 North America Neprilysin Sales by Countries
  • 6.1.2 North America Neprilysin Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Neprilysin by Product
• 6.3 North America Neprilysin by End User

7 Europe

• 7.1 Europe Neprilysin by Countries
  • 7.1.1 Europe Neprilysin Sales by Countries
  • 7.1.2 Europe Neprilysin Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Neprilysin by Product
• 7.3 Europe Neprilysin by End User

8 Asia Pacific

• 8.1 Asia Pacific Neprilysin by Countries
  • 8.1.1 Asia Pacific Neprilysin Sales by Countries
  • 8.1.2 Asia Pacific Neprilysin Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Neprilysin by Product
• 8.3 Asia Pacific Neprilysin by End User

9 Central & South America

• 9.1 Central & South America Neprilysin by Countries
  • 9.1.1 Central & South America Neprilysin Sales by Countries
  • 9.1.2 Central & South America Neprilysin Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Neprilysin by Product
• 9.3 Central & South America Neprilysin by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Neprilysin by Countries
  • 10.1.1 Middle East and Africa Neprilysin Sales by Countries
  • 10.1.2 Middle East and Africa Neprilysin Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Neprilysin by Product
• 10.3 Middle East and Africa Neprilysin by End User

11 Company Profiles

• 11.1 Bioprojet SCR
  • 11.1.1 Bioprojet SCR Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Bioprojet SCR Neprilysin Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Bioprojet SCR Neprilysin Products Offered
  • 11.1.5 Bioprojet SCR Recent Development
• 11.2 Novartis AG
  • 11.2.1 Novartis AG Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Novartis AG Neprilysin Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Novartis AG Neprilysin Products Offered
  • 11.2.5 Novartis AG Recent Development
• 11.3 Pharmaleads SA
  • 11.3.1 Pharmaleads SA Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Pharmaleads SA Neprilysin Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Pharmaleads SA Neprilysin Products Offered
  • 11.3.5 Pharmaleads SA Recent Development
• 11.4 Theravance Biopharma Inc
  • 11.4.1 Theravance Biopharma Inc Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Theravance Biopharma Inc Neprilysin Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Theravance Biopharma Inc Neprilysin Products Offered
  • 11.4.5 Theravance Biopharma Inc Recent Development

12 Future Forecast

• 12.1 Neprilysin Market Forecast by Regions
  • 12.1.1 Global Neprilysin Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Neprilysin Revenue Forecast by Regions 2019-2025
• 12.2 Neprilysin Market Forecast by Product
  • 12.2.1 Global Neprilysin Sales Forecast by Product 2019-2025
  • 12.2.2 Global Neprilysin Revenue Forecast by Product 2019-2025
• 12.3 Neprilysin Market Forecast by End User
• 12.4 North America Neprilysin Forecast
• 12.5 Europe Neprilysin Forecast
• 12.6 Asia Pacific Neprilysin Forecast
• 12.7 Central & South America Neprilysin Forecast
• 12.8 Middle East and Africa Neprilysin Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Neprilysin Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details